Identifying Barriers to Statin Therapy in Diabetic Patients in a Large Ambulatory Practice

Presenter Information

Jennifer Moyer, MD, Thomas Jefferson UniversityFollow
Rachel Ehrman-Dupre, MD, Thomas Jefferson UniversityFollow
Andrew Rabovsky, MD, Thomas Jefferson UniversityFollow
Simon Newsom, MD, Thomas Jefferson UniversityFollow
Pooja Padgaonkar, MD, Thomas Jefferson UniversityFollow
Julita Mitchell, MD, Thomas Jefferson UniversityFollow
Sarah Hirsh, MD, Thomas Jefferson UniversityFollow
Madeline Taskier, MD, Thomas Jefferson UniversityFollow
Robert Wiley, MD, Thomas Jefferson University
Lilli Flink, MD, Thomas Jefferson UniversityFollow
Greta Bires, MD, Thomas Jefferson University
Geoffrey Mills, MD, Thomas Jefferson UniversityFollow

Start Date

5-28-2020 7:30 AM

End Date

5-28-2020 8:30 AM

Description

Aim 1: To understand the root cause(s) for gaps in statin therapy within a large ambulatory care practice.

Aim 2: To improve provider awareness of indications for statin therapy, as recommended by the ACC/AHA guidelines.

Aim 3: To increase the proportion of patients with diabetes at our practice that are on statin therapy.

Keywords

diabetes, statin use

Comments

Presented at the 2020 House Staff Quality Improvement and Patient Safety Conference